Check out our most popular compounded medications! Get Started
Methylphenidate HCl 15 mg Slow Release Capsules (Gluten Free) are designed to treat conditions such as ADHD, Narcolepsy, Depression, and Bipolar Disorder. These capsules are formulated with Methocel E4M, a controlled-release polymer, which ensures the gradual release of the active ingredient over an extended period. This slow release mechanism offers sustained therapeutic effects, reduces the need for frequent dosing, and improves patient compliance. The formulation is also gluten-free, making it suitable for individuals with dietary restrictions.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Methylphenidate HCl 15 mg Slow Release Capsules (Gluten Free) is a compounded formulation designed to treat a variety of conditions such as Attention Deficit Hyperactivity Disorder (ADHD), Narcolepsy, Sleep Apnea, and Depression. This medication is formulated with Methocel E4M, a type of controlled-release polymer, which ensures the gradual release of the encapsulated active ingredient over an extended period of time. This slow release mechanism offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance, particularly for medications requiring a controlled and prolonged release profile.
Methylphenidate HCl is a stimulant medication that functions by increasing the levels of dopamine and norepinephrine in the brain. This action can significantly improve focus and concentration. It is also used to manage narcolepsy, a condition characterized by excessive daytime sleepiness. Furthermore, it can be beneficial in treating Sleep Apnea and Depression.
It is also important to discuss any other medications you are currently taking with your healthcare provider before starting this medication to avoid any potential drug interactions.
These capsules are gluten-free, making them a suitable choice for individuals with gluten sensitivities or celiac disease. This formulation ensures that patients with dietary restrictions can safely take their medication without worrying about adverse reactions.
If you have any questions about Methylphenidate HCl 15 mg Slow Release Capsules (Gluten Free) or any other medication, please do not hesitate to reach out. We are a team of compounding pharmacists dedicated to providing comprehensive information and support to ensure optimal patient care and treatment outcomes.
This compounded formulation of Methylphenidate HCl 15 mg Slow Release Capsules (Gluten Free) is designed to provide a controlled and prolonged release of the active ingredient, Methylphenidate HCl. This is achieved through the use of Methocel E4M, a type of controlled-release polymer. The slow release of the medication offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance, particularly for conditions that require a controlled and prolonged release profile.
Methylphenidate HCl is a central nervous system stimulant that works by increasing the amount of certain natural substances in the brain that are needed to control behavior and attention. This formulation is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD), Narcolepsy, Sleep Apnea, and Depression. However, it is not recommended for use in children under 6 years of age.
For ADHD, this formulation may help improve concentration, focus, and attention, and may also help reduce impulsivity and hyperactivity. However, it should not be used as a substitute for appropriate behavior modification and psychosocial interventions.
For Narcolepsy and Sleep Apnea, this formulation may help reduce daytime sleepiness and improve alertness. However, it should not be used as a substitute for appropriate lifestyle modifications and other treatments.
For Depression, this formulation may help improve mood and reduce feelings of sadness. However, it should not be used as a substitute for appropriate psychotherapy and other treatments.
It is important to note that Methylphenidate HCl 15 mg Slow Release Capsules (Gluten Free) may cause side effects such as insomnia, headache, nausea, stomach pain, decreased appetite, weight loss, dizziness, and irritability. If you experience any of these side effects, contact your healthcare provider.
If you have any questions about using Methylphenidate HCl 15 mg Slow Release Capsules (Gluten Free) to treat any of the above-mentioned disease states, please reach out to your healthcare provider.
Methylphenidate HCl 15 mg Slow Release Capsules (Gluten Free) is a compounded formulation designed to treat a range of conditions including ADHD, Narcolepsy, Attention Deficit Hyperactivity Disorder, Sleep Apnea, and Depression. This medication functions by enhancing the levels of specific neurotransmitters in the brain, such as dopamine and norepinephrine, which can aid in improving focus, concentration, and alertness.
The slow-release formulation, made with Methocel E4M, a controlled-release polymer, ensures the gradual release of the active ingredient over an extended period. This provides sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance, particularly for medications that require a controlled and prolonged release profile.
For patients with ADHD, this formulation can help improve focus and concentration, and reduce impulsivity and hyperactivity, potentially leading to improved academic performance and social functioning. In the case of Narcolepsy, it can help reduce daytime sleepiness and enhance alertness.
Similarly, for patients with Attention Deficit Hyperactivity Disorder, this medication can aid in improving focus and concentration, and reducing impulsivity and hyperactivity. For those with Sleep Apnea, it can help reduce daytime sleepiness and enhance alertness. In the case of Depression, Methylphenidate HCl 15 mg Slow Release Capsules (Gluten Free) can help improve mood and reduce feelings of sadness and hopelessness.
While generally well tolerated, this medication may cause side effects such as headache, nausea, insomnia, and decreased appetite. It is crucial to discuss any potential side effects with your healthcare provider before starting this medication. If you have any questions about Methylphenidate HCl 15 mg Slow Release Capsules (Gluten Free) or how it can help treat your condition, please consult with your healthcare provider.
Methylphenidate HCl 15 mg Slow Release Capsules (Gluten Free) are meticulously formulated with Methocel E4M, a specialized controlled-release polymer. This innovative design ensures the gradual release of the encapsulated medication over an extended period, providing sustained therapeutic effects. This slow-release mechanism not only reduces the frequency of dosing but also enhances patient compliance, particularly for medications that necessitate a controlled and prolonged release profile.
While primarily used for attention deficit hyperactivity disorder (ADHD), these capsules can also be employed to manage a variety of other conditions. These include obesity, fatigue, and sleep disorders. Off-label uses have seen it being utilized to treat cognitive deficits in patients who have suffered traumatic brain injuries, strokes, and dementia. It has also shown promise in managing chronic pain and alleviating symptoms of opioid withdrawal.
However, it is crucial to understand that methylphenidate should not be used to treat any condition without the guidance and supervision of a healthcare professional. Patients are strongly advised to discuss potential risks and benefits with their healthcare provider before initiating treatment. This ensures the safe and appropriate use of the medication, tailored to the individual's specific health needs and circumstances.
Methylphenidate HCl 15 mg Slow Release Capsules is a medication that is formulated with Methocel E4M, a type of controlled-release polymer. This formulation is designed to gradually release the encapsulated medication over an extended period of time.
Methocel E4M is a controlled-release polymer that allows the medication to be released gradually over an extended period of time. This offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance for medications requiring a controlled and prolonged release profile.
Slow release capsules offer several benefits. They provide sustained therapeutic effects, reduce the need for frequent dosing, and improve patient compliance. This is particularly beneficial for medications that require a controlled and prolonged release profile.
Yes, Methylphenidate HCl 15 mg Slow Release Capsules are gluten-free.
The slow release mechanism works by gradually releasing the encapsulated medication over an extended period of time. This is achieved through the use of a controlled-release polymer, Methocel E4M, in the formulation.
Each capsule contains 15 mg of Methylphenidate HCl.
The advantage of using Methylphenidate HCl 15 mg Slow Release Capsules over regular capsules is that they provide a controlled and prolonged release of the medication. This results in sustained therapeutic effects and reduces the need for frequent dosing.
Patients who require a controlled and prolonged release of medication can benefit from using Methylphenidate HCl 15 mg Slow Release Capsules. This includes patients who have difficulty adhering to a frequent dosing schedule.
Methylphenidate HCl 15 mg Slow Release Capsules should be used as directed by a healthcare professional. It is important to discuss your medical history and current medications with your healthcare provider before starting any new medication.
If you miss a dose of Methylphenidate HCl 15 mg Slow Release Capsules, take it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses. Always consult your healthcare provider if you have any questions or concerns.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
This preparation is a controlled substance. Additional prescribing, refill, and shipping restrictions apply, and the states Bayview can dispense it to are narrower than for non-controlled preparations.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
